Kronox Lab Sciences Limited

Kronox Lab Sciences Limited

Kronox Lab Sciences Limited has received a public announcement regarding an open offer by Indo Borax and Chemicals Limited and Zenrock Chemicals Private Limited to acquire up to 95,70,000 equity shares of the company, representing 25.79% of the voting share capital.

Kronox Lab Sciences Limited

IIFL Capital Services, Indo Borax & Chemicals, and Zenrock Chemicals have submitted a public announcement for the attention of Kronox Lab Sciences' public shareholders, citing Regulation 3(1) and Regulation 4 read with Regulations 13(1), 14, and 15(1) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended.

Kronox Lab Sciences Limited

Kronox Lab Sciences Limited has announced that Indo Borax and Zenrock Chemicals will acquire a 64.26% stake in the company for Rs. 246.12 crore. The acquisition is expected to be completed within three months.

Kronox Lab Sciences Limited

Kronox Lab Sciences Limited has informed the Exchange regarding 'Promoters Informed The Company About The SPA'. The promoters have executed a Share Purchase Agreement with Indo Borax & Chemicals Limited and Zenrock Chemicals Private Limited for the sale of 2,38,44,000 equity shares, constituting approximately 64.26% of the total paid-up equity share capital, to the Acquirer. The Acquirer along with Zenrock Chemicals Private Limited are required to make a mandatory tender offer to the public shareholders of the Company in accordance with Regulation 3(1) and Regulation 4 of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Kronox Lab Sciences Limited

Kronox Lab Sciences Limited has informed the Exchange regarding 'Announcement Of SPA Executed By Promoter'. The promoters have executed a Share Purchase Agreement with Indo Borax & Chemicals Limited and Zenrock Chemicals Private Limited for the sale of 2,38,44,000 equity shares, constituting approximately 64.26% of the total paid-up equity share capital of the Company.

Kronox Lab Sciences Limited

Kronox Lab Sciences Limited has informed the Exchange about Copy of Newspaper Publication regarding unaudited financial results for the quarter ended June 30, 2026.

Kronox Lab Sciences Limited

Kronox Lab Sciences Limited has informed the Exchange that the Record date for the purpose of Dividend is 09-Sep-2026.

Kronox Lab Sciences Limited

Kronox Lab Sciences Limited has informed the Exchange regarding the outcome of its Board Meeting held on August 12, 2026, where the Board considered and approved the unaudited standalone financial results for the quarter ended June 30, 2025, and other matters including the appointment of Cost Auditors for the year 2026-27.

Kronox Lab Sciences Limited

Kronox Lab Sciences Limited has announced the outcome of its board meeting, where it considered and approved the unaudited standalone financial results for the quarter ended June 30, 2026. The company also fixed the date of its 17th Annual General Meeting (AGM) and record date. Additionally, it appointed M/s. Diwanji & Associates as Cost Auditors for the year 2026-27.

Kronox Lab Sciences Limited

Kronox Lab Sciences Limited has responded to the National Stock Exchange's inquiry regarding a significant increase in volume of its shares, stating that the company has disclosed all material information and that management is not connected to the increase in volume.

Kronox Lab Sciences Limited

Kronox Lab Sciences Limited has seen a significant increase in trading volume, prompting the exchange to seek clarification from the company.

Kronox Lab Sciences Limited

Kronox Lab Sciences Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2026, regarding the details of securities dematerialized/rematerialized.

Kronox Lab Sciences Limited

Kronox Lab Sciences Limited has closed its trading window for insiders due to SEBI regulations, effective from July 1, 2026, until 48 hours after the announcement of unaudited financial results for the quarter ending June 30, 2026.